Skip to content
CHI Podcasts cover art

All episodes

CHI Podcasts, 255 episodes. Page 2 of 3.

#
Title
101

Molecular Diagnostics Europe 2017 | Early Detection of Cancer: Myth or Reality?

102

Molecular Med Tri-Con 2017 | Using Big Data to Create Better Precision Medicine

103

SCOPE 2017 | Clinical Trials: Patient Centricity and Wearables

104

SCOPE 2017 | Managing Precision Medicine Clinical Trials

105

PepTalk 2017 | From Protein Science R&D to Therapeutics: Expert Insights (Part 2)

106

PepTalk 2017 | From Protein Science R&D to Therapeutics: Expert Insights (Part 1)

107

Discovery on Target 2016 | Advances and Challenges in Histone Demethylase Inhibitors

108

PEGS Europe 2016 | Evolution of Recombinant Protein Expression

109

Biobanking Congress 2016 | Biobanking Quality Control and Centralization

110

Biobanking Congress 2016 | Sample Preprocessing, Circulating Nucleic Acids, and Clinical Data

111

Biobanking Congress 2016 | PDX Models and Biobanking for Preclinical Drug Development

112

Next Generation Dx Summit 2016 | Combining Whole Genome Sequencing with Clinical Care

113

Next Generation Dx Summit 2016 | Transitioning Basic Research Into Actual Diagnostics

114

PEGS Europe 2016 | Immune Checkpoint in Melanoma

115

Next Generation Dx Summit 2016 | Digital PCR Changing the Way Scientists Conduct Research

116

PEGS Europe 2016 | Display and Signaling of CAR Molecules

117

Next Generation Summit DX 2016 | NGS Pricing and Precision Medicine Implementation in the Clinic

118

World Preclinical Congress 2016 | Immunosequencing for Cancer Immunotherapy Development

119

Bio-IT World Expo 2016 | Visualizing Genomic Data: Spotlight on IOBIO

120

Next Generation Dx Summit 2016 | The Microbiome and Human Reproduction

121

World Preclinical Congress 2016 | Microfluidic 3D Cell Cultures and Organ Models for Drug Testing

122

Liquid Biopsy Summit 2016 | The Potential of Extracellular RNAs

123

World Preclinical Congress 2016 | A Conversation on Modern Lead Generation Strategies

124

World Preclinical Congress 2016 | Challenges and Future Directions of Blood-Brain Barrier Research

125

Bioprocessing Summit 2016 | Applications of AU-FDS to High-Concentration Antibody Interactions

126

Liquid Biopsy Summit 2016 | Molecular Diagnostics and Liquid Biopsy Sample Prep

127

World Preclinical Congress 2016 | Animal Models and Combination Therapy

128

Strategic Alliance Management Congress 2016 | Sponsor-CRO Strategic Partnerships

129

Molecular Diagnostics Europe 2016 | Ethical Challenges in Preimplantation Testing: What’s Next?

130

Bio-IT World Expo 2016 | Sharing Genetic Data in Clinics, Ethics and Pediatrics

131

Molecular Diagnostics Europe 2016 | Cell-free DNA Prenatal Testing

132

Molecular Diagnostics Europe 2016 | Advances in NIPT Technology at Sequenom

133

Bio-IT World 2016 | Improving Clinical Research and Patient Care with Health Informatics

134

Oligonucleotide Theapeutics & Delivery 2016 | The Resurgence of Oligonucleotide Therapeutics

135

PEGS Boston 2016 | Phenotypic Screening for Novel Antibody Targets in the Tumor Microenvironment

136

Molecular Med Tri-Con 2016 | Next-Generation Sequencing for Detecting Antimicrobial Resistance

137

Molecular Diagnostics Europe 2016 | The Clinical Implication of Liquid Biopsies

138

Tri-Con 2016 | Metabolomics for Sepsis: Predictive Biomarkers

139

Molecular Diagnostics Europe 2016 | Mitochondrial DNA

140

Molecular Diagnostics Europe 2016 | Implementation of POCT Quality Standards

141

PepTalk 2016 | Every Protein Is Different: Difficult Targets, GPCRs and Drug Discovery

142

Advances in Prenatal Molecular Diagnostics 2015 | Cell-free DNA Prenatal Testing

143

Reproductive Genetic Diagnostics 2015 | The Latest Technologies for PGD Testing

144

PEGS Europe 2015 | CHO Cells and Recombinant Protein Production across Expression Platforms

145

Reproductive Genetic Diagnostics 2015 | Genetic Diagnostics for Recurrent Pregnancy Loss

146

Discovery on Target 2015 | Targeting The Unfolded Protein Response

147

Bonus Podcast: Histone Methyltransferase and Demethylase Inhibitor Discovery

148

Discovery on Target 2105 | Histone Methyltransferase and Demethylase Inhibitor Discovery

149

Next Generation Dx Summit 2015 | Blood-Based Genotyping of Colorectal Cancer Patients

150

Next Generation Dx Summit 2015 | Metabolomics for Infectious Disease: A Focus on Sepsis

151

Next Generation Dx Summit 2015 | Biomarkers for Infectious Disease

152

Biobanking Congress 2015 | Rapid Tissue Procurement and Robust Biospecimen Data for Cancer Research

153

Next Generation Dx Summit 2015 | Technological Advancements for Diagnostics Sequencing

154

Discovery on Target 2015 | Targeting DUBs

155

Biobanking Congress 2015 | The Best Biobank Is an Empty Biobank

156

Next Generation Dx Summit 2015 | POC in the Pharmacy: Practical, Legal, and Future Perspectives

157

Sample Prep Technologies 2015 | Sample Preparation and Specimen Quality for NGS assays

158

Chemical Biology for Target Validation 2015 | Targeting the Stress Chaperome in Cancer

159

Strategic Alliance Management Congress 2015 | Setting a New Standard in Alliance Management

160

PEGS Boston 2015 | Identification and Translation of Optimal Immunotherapy Combinations

161

The Clinical Genome Conference 2015 | Returning Genomic Incidental Findings to Patients

162

World Preclinical Congress 2015 | Tissue Stem Cells, Tumors, Toxicity and Time

163

Bio-IT World 2015 | Life Sciences IT Risk Management, Cloud Security and Regulatory Compliance

164

WPC 2015 | Pain and the Brain: Using Patient-Derived Neurons for Preclinical Phenotypic Screening

165

TCGC 2015 | Driven by “Why”: Genomic Complexity, Public Engagement and Data Management

166

Molecular DX Europe 2015 | COLD-PCR for Liquid Biopsy: Current Impact and Future Directions

167

TCGC 2015 | Breast Cancer Genomics, Predictive Data and Therapy Guidance

168

Bio-IT World 2015 | The Genomics Data Privacy Landscape

169

PEGS Boston 2015 | Analytical Technologies for Characterizing Circulating ADC Species

170

PEGS China 2015 | Synthetic Antibodies for Ebola Virus Immunotherapy and Research

171

Bio-IT 2015 | Health IT Compliance, Data Security Risk Management and Regulations

172

MDXE 2015 | How Will the New Regulation Change the IVD Landscape in Europe

173

BioIT World 2015 | Applying Data Science, Bioinformatics and Networks to Cancer Genomics

174

Next Generation Summit 2015 | Point-of-Care Diagnostics in CVS' MinuteClinics

175

SCOPE 2015 | Effective Patient Engagement and Education for Clinical Trials

176

SCOPE 2015 | Postmarketing Regulatory Environment in Europe

177

MMTC 2015 | The Future of Digital Pathology

178

MMTC 2015 | Inaugural Swimming with the Sharks Competition

179

SCOPE 2015 | Managing Drug Safety Challenges from Clinical Trials to Post Marketing Stages

180

PepTalk 2015 | Strategies for Cross the Blood-Brain Barrier with Antibody Therapeutics

181

PepTalk 2015 | Baculovirus-Insect Cell Systems for Protein Production

182

PepTalk 2015 | CHO Cells and Computational Models for Recombinant Protein Expression

183

PepTalk 2015 | Enabling High-Throughput Protein Expression

184

PepTalk 2015 | Leachables and Extractables: Updates, Best Practices and Recommendations

185

PepTalk 2015 | Analytical Control Strategy for Novel Complex Recombinant Biotherapeutics

186

EBRS 2014 | Impact of PAMA on the Molecular Diagnostics Market Environment

187

EBRS 2014 | Reimbursement and Adoption of Personalized Genomic Medicine

188

FAST Congress 2014 | Understanding Drug Toxicity

189

Discovery On Target 2014 | Development of Histone Demethylase Inhibitors

190

FAST Congress 2014 | “Sci-Fi Come to Life”

191

Anti-Bacterial Drug Development Summit 2014 | Developing Robust Platforms

192

Anti-Bacterial Drug Development Summit 2014 | New Antibiotic Commercialization

193

Discovery On Target 2014 | Targeting BET Bromodomains in Cancer

194

BioBanking and Cancer at the Crossroads 2014 | Impact of Biobanks and Fit-for-Purpose Biospecimens

195

Cancer Diagnosis at the Crossroads 2014 | Clinical Applications of NGS Gene Panels

196

BioBanking and Cancer Diagnosis Podcast 2014 | Precise Cancer Surgeries and Drug Treatments

197

Next Generation Summit 2014 | Preview of the Panel Discussion on IMPLEMENTATION OF MOLECULAR TESTING

198

BioBanking and Cancer Diagnosis Podcast 2014 | The Business of Biobanking

199

Next Generation Summit 2014 | Companion Diagnostics

200

Next Generation Summit 2014 | Single-Cell Sequencing and Complex Cancer Genome Analysis